title: [Informed consent for factor V Leiden mutation screening before recommending use of combined hormonal contraceptives or hormone replacement therapy ].
authors.affiliation: Gynekologicko-porodnická klinika 1. LF UK a VFN v Praze Apolinárská 18 128 00 Praha 2. david.cibula@iol.cz
authors.forename: D
authors.initials: D
authors.lastname: Cibula
authors.forename: J
authors.initials: J
authors.lastname: Kvasnicka
authors.forename: P
authors.initials: P
authors.lastname: Salaj
authors.forename: Z
authors.initials: Z
authors.lastname: Vorlová
authors.forename: V
authors.initials: V
authors.lastname: Unzeitig
authors.forename: J
authors.initials: J
authors.lastname: Zivný
mesh_terms: D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects*; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D005165:Factor V / Q000235:genetics*; D005260:Female; D005819:Genetic Markers; D006801:Humans; D017354:Point Mutation; D012307:Risk Factors; D019851:Thrombophilia / Q000175:diagnosis* / Q000235:genetics
chemical_list: D003278:Contraceptives, Oral, Hormonal; D005819:Genetic Markers; C095381:factor V Leiden; D005165:Factor V